FDA Orange Book · active-ingredient family
Ferric maltol
Ferric maltol is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:ACCRUFER · NDA 212320
1
Brand (NDA)
0
Generics (ANDA)
3
Listed patents
1
Exclusivity periods
Brand (NDA) products · capsule
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ACCRUFERRLD | SHIELD TX | NDA 212320 | — | Jul 25, 2019 |
Marketing exclusivity (1)
- NPPNew patient population exclusivity (3 years)
Dec 19, 2028
in 2 yr 6 mo
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9248148 | Mar 29, 2031 | in 4 yr 10 mo | U-2603 |
| 10179120 | Jan 06, 2035 | in 8 yr 8 mo | U-2603 |
| 9802973 | Oct 23, 2035 | in 9 yr 6 mo | SubstanceProductU-2603 |
Ferric maltol — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

